4.5 Article

Nanocarrier with self-antioxidative property for stabilizing and delivering ascorbyl palmitate into skin

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 102, Issue 8, Pages 2770-2779

Publisher

WILEY-BLACKWELL
DOI: 10.1002/jps.23641

Keywords

curcumin; antioxidant; ascorbyl palmitate; skin delivery; polymeric drug carrier; nanoparticles; transdermal drug delivery; skin; stability

Funding

  1. Thailand Research Fund [RDG5650009]
  2. Advanced Material Cluster at Chulalongkorn University
  3. higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission [CU-56-AM02]

Ask authors/readers for more resources

The concept of a nanocarrier with a self-antioxidative property to deliver and stabilize a labile drug while at the same time providing a free radical scavenging activity is demonstrated. Curcumin was grafted onto a poly(vinyl alcohol) [PV(OH)] chain, and the nanocarriers fabricated from the obtained curcumin-grafted PV(OH) polymer [CUR-PV(OH)] showed a good free radical scavenging activity. Ascorbyl palmitate (AP) could be effectively loaded into the CUR-PV(OH) at 29% by weight. The CUR-PV(OH)-encapsulated AP was 77% more stable than the free (unencapsulated) AP, and 47% more stable than AP encapsulated in the control nanocarrier with no antioxidative property [cinnamoyl-grafted PV(OH); CIN-PV(OH)]. Although coencapsulation of curcumin and AP into CIN-PV(OH) showed some improvement on the AP stability, AP was more stable when encapsulated in CUR-PV(OH). Compared with the free AP, encapsulated AP within the CUR-PV(OH) nanocarriers showed not only a better penetration into pig skin dermis via hair follicle pathway followed by the release and diffusion of the AP, but also a greater AP stability after skin application. Although a proof of principle is shown for CUR-PV(OH) and AP, it is likely that other carriers of the same principal could be designed and applied to different oxidation-sensitive drugs. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:2770-2779, 2013

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available